Finch Therapeutics Group, Inc. — Contributions, Lobbying & Contracts | Poliscope

Finch Therapeutics Group, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

FNCH

organization

SIC: 2836

SEC Insider

$31.4M

77 transactions

Summary

Finch Therapeutics Group, Inc. (FNCH) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $31.4MSales: $38K15 insiders

Date	Insider	Type	Value
2024-03-28	SMISEK JEFFERY A	Sell	$17K
2023-11-22	SMISEK JEFFERY A	Sell	$5K
2022-10-21	Vittiglio Joseph(Chief Business & Legal Officer)	Sell	$5K
2022-10-21	Blaustein Marc(Chief Operating Officer)	Sell	$5K
2024-03-28	SMISEK JEFFERY A	Sell	$4K
2023-02-21	Blaustein Marc(Chief Operating Officer)	Sell	$2K
2023-06-09	Graf Susan E	Buy	$1K
2024-06-07	SMISEK JEFFERY A	G	$0
2024-06-07	SMISEK JEFFERY A	G	$0
2024-05-20	SMISEK JEFFERY A	G	$0
2023-06-09	Blischak Matthew P.(Chief Executive Officer)	A	$0
2023-06-08	Graf Susan E	A	$0
2023-06-08	FERRANTE DOMENIC J	A	$0
2023-06-08	Haft Nicholas	A	$0
2023-06-08	SMISEK JEFFERY A	A	$0
2023-06-08	Lange Christian H.	A	$0
2023-06-08	Blischak Matthew P.(Chief Executive Officer)	A	$0
2023-06-08	Shumway Chris	A	$0
2022-06-13	Haft Nicholas	A	$0
2022-06-13	SMISEK JEFFERY A	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR